14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Feb 20, 2019 $0.0860 $0.0960 $0.0860 $0.0860 30 365
Feb 19, 2019 $0.0850 $0.0992 $0.0850 $0.0950 15 706
Feb 15, 2019 $0.0930 $0.100 $0.0800 $0.0925 18 123
Feb 14, 2019 $0.0720 $0.0930 $0.0720 $0.0930 23 677
Feb 13, 2019 $0.0720 $0.0977 $0.0720 $0.0930 69 557
Feb 12, 2019 $0.0999 $0.0999 $0.0700 $0.0976 13 705
Feb 11, 2019 $0.0900 $0.100 $0.0800 $0.0998 169 335
Feb 08, 2019 $0.0900 $0.0900 $0.0850 $0.0900 50 953
Feb 07, 2019 $0.0820 $0.100 $0.0750 $0.0900 82 871
Feb 06, 2019 $0.0660 $0.0850 $0.0658 $0.0836 40 936
Feb 05, 2019 $0.0650 $0.0820 $0.0650 $0.0810 44 950
Feb 04, 2019 $0.0900 $0.0900 $0.0650 $0.0840 204 072
Feb 01, 2019 $0.0555 $0.0830 $0.0555 $0.0800 125 950
Jan 31, 2019 $0.0550 $0.0750 $0.0550 $0.0700 5 839
Jan 30, 2019 $0.0550 $0.0740 $0.0550 $0.0740 15 624
Jan 29, 2019 $0.0680 $0.0750 $0.0550 $0.0750 232 436
Jan 28, 2019 $0.0550 $0.0676 $0.0550 $0.0676 1 657
Jan 25, 2019 $0.0550 $0.0680 $0.0550 $0.0570 12 066
Jan 24, 2019 $0.0526 $0.0680 $0.0526 $0.0606 11 304
Jan 23, 2019 $0.0680 $0.0680 $0.0640 $0.0640 13 086
Jan 22, 2019 $0.0560 $0.0674 $0.0550 $0.0674 29 592
Jan 18, 2019 $0.0550 $0.0680 $0.0550 $0.0680 37 086
Jan 17, 2019 $0.0630 $0.0680 $0.0500 $0.0674 74 814
Jan 16, 2019 $0.0620 $0.0720 $0.0620 $0.0645 32 423
Jan 15, 2019 $0.0620 $0.0720 $0.0620 $0.0620 139 522
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT